Connection

Vaithilingaraja Arumugaswami to Virus Replication

Back to Details
This is a "connection" page, showing publications Vaithilingaraja Arumugaswami has written about Virus Replication.
Vaithilingaraja Arumugaswami
Connection Strength
0.239
Virus Replication
  1. Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication. Cell Rep. 2021 04 06; 35(1):108940.
    View in: PubMed
    Score: 0.195
  2. SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery. Cell Rep. 2021 05 04; 35(5):109055.
    View in: PubMed
    Score: 0.012
  3. SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition. Nat Commun. 2021 03 25; 12(1):1876.
    View in: PubMed
    Score: 0.012
  4. Determination of system level alterations in host transcriptome due to Zika virus (ZIKV) Infection in retinal pigment epithelium. Sci Rep. 2018 07 25; 8(1):11209.
    View in: PubMed
    Score: 0.010
  5. Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein. Proc Natl Acad Sci U S A. 2017 02 21; 114(8):2018-2023.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.